Education
About Us
Working with TipRanks
Follow Us
Enzolytics (ENZC)
:ENZC
ENZC Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume3.47M
Average Volume (3M)7.00M
Market Cap
$3.15M
Enterprise ValueN/A
Total Cash (Recent Filing)$996.97K
Total Debt (Recent Filing)$431.02K
Price to Earnings (P/E)―
Beta-0.45
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
May 23, 2012Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding3,941,644,000
10 Day Avg. Volume5,579,202
30 Day Avg. Volume6,996,285
Standard Deviation1.49
R-Squared0.00100
Alpha0.27
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
0.05% Other Institutional Investors
99.95% Public Companies and
Individual Investors
ENZC FAQ
What was Enzolytics ’s price range in the past 12 months?
Enzolytics lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Enzolytics ’s market cap?
Enzolytics ’s market cap is $3.15M.
When is Enzolytics ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Enzolytics ’s earnings last quarter?
Currently, no data Available
Is Enzolytics overvalued?
According to Wall Street analysts Enzolytics ’s price is currently Overvalued.
Does Enzolytics pay dividends?
Enzolytics pays a Notavailable dividend of $156.25 which represents an annual dividend yield of N/A. See more information on Enzolytics dividends here
What is Enzolytics ’s EPS estimate?
Enzolytics ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enzolytics have?
Enzolytics has 3,941,644,000 shares outstanding.
What happened to Enzolytics ’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Enzolytics ?
Currently, no hedge funds are holding shares in ENZC
---
Company Description
Enzolytics
Enzolytics, Inc. is a development stage company, which engages in the research and development on the operations and treatment of HIV/Aids virus. It focuses on the commercialization of the license rights of the IPF for the treatment of Aids and Hepatitis C as well as potential other treatments for life threatening diseases. The company was founded on July 28, 2004 and is headquartered in Monrovia, CA.
---
Ibio
―
Soligenix
―
CytoDyn
―
Artificial Intelligence Technology Solutions
―
Innerscope Hearing Technologies
―
---